Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Predicting Multiple Sclerosis Risk: Scientific Constraints, Emerging Methods, and Translational Opportunities
Genetics
Predicting Multiple Sclerosis Risk: Scientific Constraints, Emerging Methods, and Translational Opportunities

14, Feb 2026

2
Predicting Multiple Sclerosis Risk: Scientific Constraints, Emerging Methods, and Translational Opportunities
Genetics
Genetic Architecture of Intrathecal IgG Synthesis in Multiple Sclerosis: Integrating GWAS Signals, HLA Haplotypes, and Polygenic Risk

13, Feb 2026

3
Decoding Multiple Sclerosis Risk with Polygenic Scores: Validation Across Cohorts and Links to Long-Term Brain Atrophy
Genetics
Decoding Multiple Sclerosis Risk with Polygenic Scores: Validation Across Cohorts and Links to Long-Term Brain Atrophy

12, Feb 2026

4
Polygenic Risk Scores and Lifetime Multiple Sclerosis Risk: Translating Genetic Susceptibility Into Absolute Probability
Genetics
Polygenic Risk Scores and Lifetime Multiple Sclerosis Risk: Translating Genetic Susceptibility Into Absolute Probability

12, Feb 2026

5
Ancestry-Dependent Performance of a Multiple Sclerosis Polygenic Risk Score in the All of Us Research Program
Genetics
Ancestry-Dependent Performance of a Multiple Sclerosis Polygenic Risk Score in the All of Us Research Program

11, Feb 2026

Categories:
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis

09, Jun 2025

Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments
Genetics
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments

10, Jun 2025

Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS
Genetics
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS

11, Jun 2025

Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?
Genetics
Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?

12, Jun 2025